Talphera Inc TLPH.OQ reported a quarterly adjusted loss of 15 cents per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of -40 cents. The mean expectation of three analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -24 cents to -22 cents per share.
Reported revenue was zero; analysts expected zero.
Talphera Inc's reported EPS for the quarter was a loss of 15 cents.
The company reported a quarterly loss of $3.83 million.
Talphera Inc shares had risen by 2.2% this quarter and gained 23.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," "hold" and "sell" or "strong sell."
The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Talphera Inc is $4.25
This summary was machine generated from LSEG data August 15 at 04:07 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING |
ESTIMATE |
ACTUAL |
BEAT, MET, MISSED |
Jun. 30 2024 |
-0.23 |
-0.15 |
Beat |
Mar. 31 2024 |
-0.22 |
-0.16 |
Beat |
Dec. 31 2023 |
-0.20 |
-0.25 |
Missed |
Sep. 30 2023 |
-0.28 |
-0.08 |
Beat |